六國化工(600470.SH):控股股東前期籌劃重大事項終止
格隆匯2月26日丨六國化工(600470.SH)公佈,2023年11月8日公司發佈《關於控股股東的股東籌劃重大事項的進展暨復牌的公吿》(公吿編號2023-058),公司控股股東的股東與萬華化學簽署的《股權變更框架協議》,擬通過各方合作,萬華化學將可能成為銅化集團化工業務的控股股東,進而獲得公司的控制權。
公司於2024年2月26日收到控股股東銅陵化學工業集團吿知函:雙方經過充分討論和協商後決定,《股權變更框架協議》中涉及六國化工可能導致實際控制人發生變更事項終止執行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.